Literature DB >> 72160

Interactions of murine leukemia virus core components: characterization of reverse transcriptase packaged in the absence of 70S genomic RNA.

B I Gerwin, J G Levin.   

Abstract

Virions produced by cells in the presence of actinomycin D (Act D virions) contain reverse transcriptase but are deficient in 70S genomic RNA. To assess the role of genomic RNA in encapsidation of a functional reverse transcriptase and to study the interaction of the enzyme and its template in the cores of intact virions, the reverse transcriptase enzymes of normal and Act D virions were compared. The enzymes were indistinguishable by column chromatography, sedimentation velocity, or template/primer preferences. In addition, these enzymes showed equal sensitivity to inactivation by antibodies directed against Rauscher murine leukemia virus DNA polymerase. The enzymes from Act D and normal virions had similar thermal decay rates and were both protected against heat denaturation by natural and synthetic template/primers. By these criteria, the DNA polymerase molecules synthesized and assembled into virions in the absence of genomic RNA are identical to those packaged under normal conditions. Additional studies designed to measure protection of reverse transcriptase by genomic RNA were carried out by comparing the thermal lability of the enzyme in intact Act D and normal virions. The thermal decay rate of reverse transcriptase in Act D virions was identical to that in control virions. In contrast to the lability of the virion-associated enzyme, however, genomic RNA in control virions was stable to heat treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72160      PMCID: PMC515957          DOI: 10.1128/JVI.24.2.478-488.1977

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Analysis on the reproducing and cell-transforming capacities of a temperature sensitive mutant (ts 334) of avian sarcoma virus B77.

Authors:  M Owada; K Toyoshima
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

2.  Identification of a large polypeptide precursor of avian oncornavirus proteins.

Authors:  V M Vogt; R Eisenman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

3.  An oligonucleotide affinity column for RNA-dependent DNA polymerase from RNA tumor viruses.

Authors:  B I Gerwin; J B Milstien
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

4.  Quantitation of avian RNA tumor virus reverse transcriptase by radioimmunoassay.

Authors:  A Panet; D Baltimore; T Hanafusa
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

5.  Studies on reverse transcriptase of RNA tumor viruses. I. Localization of thermolabile DNA polymerase and RNase H activities on one polypeptide.

Authors:  I M Verma
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

6.  Two active forms of RD-114 virus DNA polymerase in infected cells.

Authors:  B I Gerwin; S G Smith; P T Peebles
Journal:  Cell       Date:  1975-09       Impact factor: 41.582

7.  Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions.

Authors:  S R Tronick; J R Stephenson; I M Verma; S A Aaronson
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

8.  Primer requirement and template specificity of the DNA polymerase of RNA tumor viruses.

Authors:  D Baltimore; D Smoler
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

9.  Purification and characterization of the DNA polymerase and RNase H activities in Moloney murine sarcoma-leukemia virus.

Authors:  G F Gerard; D P Grandgenett
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

10.  Distinguishing reverse transcriptase of an RNA tumor virus from other known DNA polymerases.

Authors:  N C Goodman; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

View more
  14 in total

1.  Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line.

Authors:  L R Boone; C L Innes; C K Heitman
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA.

Authors:  J G Levin; J G Seidman
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

3.  Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity.

Authors:  J G Levin; R J Crouch; K Post; S C Hu; D McKelvin; M Zweig; D L Court; B I Gerwin
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus.

Authors:  M Aboud; Y Hassan
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

5.  Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA.

Authors:  L I Messer; J G Levin; S K Chattopadhyay
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

6.  Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule.

Authors:  B I Gerwin; A Rein; J G Levin; R H Bassin; B M Benjers; S V Kashmiri; D Hopkins; B J O'Neill
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

7.  A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation.

Authors:  Mastooreh Chamanian; Katarzyna J Purzycka; Paul T Wille; Janice S Ha; David McDonald; Yong Gao; Stuart F J Le Grice; Eric J Arts
Journal:  Cell Host Microbe       Date:  2013-02-13       Impact factor: 21.023

8.  Macromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses.

Authors:  R H Bassin; B I Gerwin; J G Levin; G Duran-Troise; B M Benjers; A Rein
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

9.  Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assembly.

Authors:  J G Levin; J G Seidman
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

10.  Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.

Authors:  J Guo; T Wu; J Bess; L E Henderson; J G Levin
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.